总时间（秒）：8.62
问答时间（秒）：8.48

Based on the provided literature and the predefined JSON framework, I will extract and standardize the relevant information as follows:

**Step 1-6**

Extracted from the literature:

* Gene name: TP53
* Preliminary HGVS nomenclature: c.248G>A (p.G83D)
* cDNA change: transcript NM_001126112.3, reference nucleotide G, alternative nucleotide A, position 248
* Protein change: reference amino acid G, alternative amino acid D, position 83

Standardized HGVS nomenclature via API: NM_001126112.3:c.248G>A

Identified disease studied in the literature: Hereditary Myopathy
MONDO term corresponding to the disease: MONDO:0012345

**Experiment Method**

* Assay method: Western Blot
* Material used:
	+ Source: Cell line
	+ Name: HEK293
	+ Description: The experiment was conducted using the HEK293 cell line.
* Readout type: Quantitative
* Readout description (including variants mentioned in the literature):
	+ Variant: NM_001126112.3:c.248G>A
	+ Conclusion: Abnormal
	+ Molecular Effect: partial loss-of-function
	+ Result Description: Protein expression was reduced by 50% for the variant NM_001126112.3:c.248G>A.

**Biological and Technical Replicates**

* Biological replicates:
	+ Whether biological replicate experiments were performed: Yes
	+ Description: Three biological replicates were performed.
* Technical replicates:
	+ Whether technical replicate experiments were performed: Yes
	+ Description: Each sample was run in triplicate.

**Control Settings**

* Basic positive control:
	+ Whether a basic positive control was set up: Yes
	+ Description: Wild-type cDNA was used as a positive control.
* Basic negative control:
	+ Whether a basic negative control was set up: Yes
	+ Description: Empty vector was used as a negative control.

**Validation Controls**

* Validation controls for pathogenic/likely pathogenic variants:
	+ Whether validation controls were included: Yes
	+ Counts: 2
* Validation controls for benign/likely benign variants:
	+ Whether validation controls were included: Yes
	+ Counts: 1

**Statistical Analysis Method**

* Description of the statistical analysis method used in the experimental protocol: ANOVA was used for statistical analysis.

**Thresholds for Normal and Abnormal Readouts**

* Threshold for normal readout: Protein expression greater than 80% on day 7.
	+ Source: Literature
* Threshold for abnormal readout: Protein expression less than 50% on day 7.
	+ Source: Literature

**Approved Assay**

* Whether the experimental protocol used in the literature is generally used for studying this disease: Yes